FDA Inspection 1169526 — Stephen A. Young PhD

Stephen A. Young PhD — FEI 3006152485

The FDA completed an inspection of Stephen A. Young PhD on May 4, 2022 in Albuquerque, NM. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 4, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Albuquerque, NM (United States)

Additional Details

Clinical Investigator (CI)